Cart
sales@molnova.com
PD 174265
CAS No. 216163-53-0
PD 174265( PD174265 | PD-174265 | N-{4-[(3-Bromophenyl)amino]quinazolin-6-Yl}propanamide )
Catalog No. M27910 CAS No. 216163-53-0
PD 174265 is an effective, selective and reversible inhibitor of epidermal growth factor receptor (EGFR) with an IC50 of 0.45 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 36 | In Stock |
|
| 5MG | 29 | In Stock |
|
| 10MG | 36 | In Stock |
|
| 25MG | 54 | In Stock |
|
| 50MG | 74 | In Stock |
|
| 100MG | 108 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePD 174265
-
NoteResearch use only, not for human use.
-
Brief DescriptionPD 174265 is an effective, selective and reversible inhibitor of epidermal growth factor receptor (EGFR) with an IC50 of 0.45 nM.
-
DescriptionPD 174265 is an effective, selective and reversible inhibitor of epidermal growth factor receptor (EGFR) with an IC50 of 0.45 nM.
-
In Vitro——
-
In Vivo——
-
SynonymsPD174265 | PD-174265 | N-{4-[(3-Bromophenyl)amino]quinazolin-6-Yl}propanamide
-
PathwayAngiogenesis
-
TargetEGFR
-
RecptorInfluenza Virus
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number216163-53-0
-
Formula Weight371.238
-
Molecular FormulaC17H15BrN4O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (336.72 mM)
-
SMILESCCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Takizawa N, et al. Anti-influenza virus activity of a salcomine derivative mediated by inhibition of viral RNA synthesis. Arch Virol. 2018 Jun;163(6):1607-1614.
molnova catalog
related products
-
WZ4002
WZ4002 is a novel, mutant-selective EGFR inhibitor for EGFR(L858R)/(T790M) with IC50 of 2 nM/8 nM.
-
Almonertinib mesylat...
Almonertinib mesylate is an irreversible inhibitor of EGFR tyrosine kinase with high selectivity for EGFR-sensitizing and T790M resistance mutations. Almonertinib mesylate can be used in the non-small cell lung cancer studies.
-
PP2
PP2, a Src family kinase inhibitor, potently inhibits Lck/Fyn with IC50 of 4 nM/5 nM.
